A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries

@inproceedings{Waning2010ALT,
  title={A lifeline to treatment: the role of Indian generic manufacturers in supplying antiretroviral medicines to developing countries},
  author={Brenda J Waning and Ellen K Diedrichsen and Suerie Moon},
  booktitle={Journal of the International AIDS Society},
  year={2010}
}
BACKGROUND Indian manufacturers of generic antiretroviral (ARV) medicines facilitated the rapid scale up of HIV/AIDS treatment in developing countries though provision of low-priced, quality-assured medicines. The legal framework in India that facilitated such production, however, is changing with implementation of the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights, and intellectual property measures being discussed in regional and bilateral free… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 2 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

A Cost Analysis of the Jan Aushadhi Scheme in India

International journal of health policy and management • 2017
View 3 Excerpts
Highly Influenced

HIV-1 drug resistance and resistance testing.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases • 2016
View 17 Excerpts
Highly Influenced

References

Publications referenced by this paper.
Showing 1-10 of 10 references

Temporal trends in generic and brand prices of antiretroviral medicines procured with donor funds in developing countries

B Waning, W Kaplan, +7 authors M Gokhale
J Gen Med • 2010
View 1 Excerpt

Seizure of generic pharmaceuticals in transit based on allegations of patent infringement: a threat to international trade, development and public welfare

F Abbott
World Intellectual Property Organization Journal • 2009
View 1 Excerpt

The Global Politics of Pharmaceutical Monopoly Power: Drug Patents, Access, Innovation and the Application of the WTO

E ’t Hoen
Doha Declaration on TRIPS and Public Health Diemen: AMB Publishers • 2009
View 1 Excerpt

Communication to all CCMs and PRs on 10% savings on round 8 Geneva: Global Fund to Fight AIDS, Tuberculosis and Malaria

W Paton
Journal of the International AIDS Society • 2008
View 1 Excerpt

India’s pharmacuetical industry on course for globalisation

U Perlitz
2008
View 1 Excerpt

Implications of bilateral free trade agreements on access to medicines.

Bulletin of the World Health Organization • 2006
View 1 Excerpt

Letter to Karel de Gucht , European Commissioner for Trade

T VonSchoen-Angerer
Bull World Health Organ • 2006

Similar Papers

Loading similar papers…